Research
Hormonal
Incretin-based therapies (GLP-1 and GLP-1/GIP dual agonists) provide superior glycemic control and weight loss compared to basal insulin in Type 2 Diabetes, with lower hypoglycemia risk.
If you have Type 2 Diabetes and need an injection, ask about GLP-1 or GLP-1/GIP agonists (like Semaglutide or Tirzepatide) before starting insulin. These drugs lower blood sugar better, help you lose weight, and carry a lower risk of dangerous low blood sugar events, though you may experience temporary stomach upset.
GoodSupportsHIGH confidence
Recent studies have shown the superiority of incretin-based therapies over basal insulin... Incretin-based therapies, such as glucagon-like peptide-1 (GLP-1) receptor agonists offer improved glycemic control, weight loss, and reduced cardiovascular risk.
Why this rating
Based on a meta-analysis of 20 studies (47 treatment arms, 11,843 patients) comparing head-to-head clinical trials.
Source
Injectable Drugs in Diabetes Treatment: Insulin versus Incretin
Kang Hee Ahn · Journal of Korean Diabetes · 2025
DOI 10.4093/jkd.2025.26.1.28
narrative_review
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →